What is the serial number for AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE?

The USPTO serial number for AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE is 99358160.

What is the registration number for AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE?

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE is registered under USPTO registration number 0.

AUJ

USPTO Trademark Record

PENDING

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

Q: Who owns the AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark?

The AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark is owned by Seqirus Inc..

Q: What class is the AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark registered in?

The AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

SN 99358160·Reg 0·Filed Aug 26, 2025

Owner Seqirus Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE (Serial No. 99358160), Registration No. 0, is a pending US trademark filed on Aug 26, 2025 by Seqirus Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Statement of Use due: April 14, 2027188 days remaining

Mark Intelligence

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 26, 2025

SERIAL

99358160

REG#

Owner

Applicant

Seqirus Inc.

Entity

Corporation

State

Address

475 Green Oaks Parkway, Holly Springs, NC, 27540

Country

Attorney

NameNancy Sabarra

Law firm

Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.

Docket

SEQS 2511370

Address

151 West 42nd St., 17th Fl., New York, NY 10036, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateAug 26, 2025

Serial Number99358160

Registration No.0

Status DateMay 21, 2026

Published for OppositionFeb 17, 2026

Mark TypeDesign with words

Attorney DocketSEQS 2511370

Status DescriptionLive and pending, first extension granted

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

17 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 22, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 21, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

May 21, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

May 21, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 14, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 17, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 17, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 11, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 22, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 19, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 18, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 18, 2026

NOTICE OF DESIGN SEARCH CODE E-MAILED

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Sep 22, 2025

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

ASSIGNED TO LIE

Sep 16, 2025

ASSIGNED TO LIE

TEAS VOLUNTARY AMENDMENT RECEIVED

Sep 09, 2025

TEAS VOLUNTARY AMENDMENT RECEIVED

NEW APPLICATION ENTERED

Aug 26, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 26, 2025

APPLICATION FILING RECEIPT MAILED

AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Seqirus Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Nancy Sabarra

Resources

Company